PATENT CLAIM ANALYSIS

Application Number: 15751547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["562", "030000"]

Abstract:
Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.

Claim (Index 16):
The compound of  claim 15 , wherein each R 7  and each R 8  is hydrogen.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.04762
- Patent Class: 562.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16320589', '14769421', '10307735', '15740462', '15312614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593193053426884
- 35 USC 102 Novelty (BERT): 0.5332480580990636
- Combined Prediction Score: 0.736712180618326
- Mean Citation Score: 338.91286
- Max Citation Score: 342.17654
- Similarity Product: 212.5644602222371

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test